Across Colombia, Belgium, Sweden, the Netherlands, Portugal, and the United States, cocaine and synthetic opioids are reshaping communities in very different ways. This investigation follows coca production, international trafficking, youth recruitment, gang violence, drug markets, fentanyl, and xylazine while examining how organized crime and addiction intersect. Through law enforcement, community organizations, people with lived experience, and public health workers, the episode connects the global cocaine trade with European gang networks and the overdose crisis in North America, as well as prevention, treatment, and harm-reduction efforts.
Prescription opioid dependence can affect people of all ages and backgrounds, including those who first encounter opioids through legitimate pain treatment. Focusing on communities in Ontario, this documentary combines personal experiences with perspectives from healthcare professionals, treatment providers, and community leaders. It examines opioid withdrawal, stigma, harm reduction, methadone treatment, counselling, and other approaches to recovery while exploring the challenges of balancing pain management with the risks of prescription opioids and responding to addiction as a public health issue.
In 2001, Portugal transformed its approach to drugs by decriminalizing possession of small amounts for personal use and shifting its focus toward health, treatment, and harm reduction. Two decades later, SBS Dateline travels to Lisbon to examine how the policy works in practice and what impact it has had on addiction, overdose deaths, and people who use drugs. Through policymakers, frontline workers, and personal stories, the investigation explores Portugal's progress, the problems that remain, and whether countries such as Australia could learn from its approach to drug policy.
Australians are among the world's biggest consumers of ecstasy, but where does MDMA actually come from? This investigation follows the drug from clandestine laboratories and chemical suppliers to international trafficking networks and the people who consume it. Travelling from Australia to the Netherlands, reporters examine MDMA production, precursor chemicals, the dark web, and the criminal networks supplying the global market. The investigation also explores Dutch drug policy and harm reduction, revealing a very different approach to drug education while examining the risks surrounding one of the world's most popular party drugs.
San Diego County has become a major battleground in the fentanyl crisis, with counterfeit pills, drug trafficking, and online drug markets contributing to a devastating rise in overdose deaths. Families, survivors, law enforcement, medical professionals, and community advocates share their experiences while examining how fentanyl reaches local communities and why young people are particularly vulnerable. The investigation also explores efforts to save lives through naloxone, fentanyl test strips, low-barrier care, and medications for opioid use disorder, showing how prevention and treatment have become critical parts of the response.
What can the United States learn from Canada’s approach to the overdose crisis? ABC7 News reporter Tara Campbell travels to British Columbia to examine harm reduction and the services designed to keep people who use drugs alive and connected to care. Through personal stories and expert perspectives, the documentary explores supervised consumption, fentanyl, homelessness, trauma, stigma, and barriers to treatment. It also looks inside Insite, North America’s first legally sanctioned supervised consumption site, while examining the broader debate over whether similar approaches could help communities struggling with overdose in the United States.
Fentanyl has transformed Ontario’s opioid crisis, affecting people who use drugs, families, healthcare workers, law enforcement, and communities across the province. This three-part series combines personal stories with expert perspectives to examine fentanyl, prescription opioid addiction, overdose, and the challenges people face when seeking treatment. It also explores harm reduction, public education, law-enforcement responses, and efforts to prevent further deaths. Along the way, people directly affected by addiction share their experiences, showing why understanding the crisis requires looking beyond the drug itself to the people and circumstances behind it.
Families, harm-reduction workers, and experts share their experiences of North Carolina’s fentanyl epidemic and the devastating toll of overdose across the state. The documentary examines how the opioid crisis evolved from prescription medications to heroin and illicit fentanyl, while exploring drug trafficking, pharmaceutical accountability, and the state’s response to rising deaths. It also looks at harm-reduction efforts, including naloxone and fentanyl test strips, and follows people working directly with communities affected by addiction. Their stories show both the human cost of the crisis and the efforts underway to prevent further loss.
What happens inside the brain when occasional drug use becomes addiction? Experts use neuroscience, brain imaging, and personal stories to explain how opioids affect dopamine, cravings, withdrawal, decision-making, and the brain’s reward system. The film also explores the roles of genetics, family history, and childhood trauma in addiction risk, while examining approaches to treatment and harm reduction, including methadone, buprenorphine, naloxone, and supervised consumption sites. Alongside the science are stories of recovery that show why addiction is increasingly understood as a treatable medical condition rather than a moral failing.
Through personal stories and community perspectives, the film examines the stigma surrounding addiction and the damage caused by shame, judgment, and misunderstanding. People in recovery, health-care professionals, law enforcement, and advocates discuss prescription opioids, heroin, overdose, and the barriers that can prevent people from seeking treatment. It also explores decriminalization and different approaches to recovery while challenging the idea that addiction is simply an individual problem, asking communities to reconsider how people with substance use disorders are treated and what meaningful support should look like.
